Skip to main content

Table 1 Comparison of patient characteristics according to lymphovascular invasion

From: Value of digital mammography in predicting lymphovascular invasion of breast cancer

Characteristics

Total

LVI = 0 (Negative)

LVI = 1 (Positive)

P

Age

122

49.99(10.17)

48.93(9.34)

0.566

History of giving birth

122

80

42

0.488

 No

5

4(80.00)

1(20.00)

 

 Yes

117

76(64.96)

41(35.04)

 

History of abortion

122

80

42

0.560

 No

86

55(63.95)

31(36.05)

 

 Yes

36

25(69.44)

11(30.56)

 

nipple discharge

122

80

42

 

 No

120

80(66.67)

40(33.33)

 

 Yes

2

0(0.00)

2(100.00)

 

CA153a

121

79

42

0.514

 Negative

117

77(65.81)

40(34.19)

 

 Positive

4

2(50.00)

2(50.00)

 

History of related illness

122

80

42

0.488

 No

117

76(64.96)

41(35.04)

 

 Yes

5

4(80.00)

1(20.00)

 

ER

122

80

42

0.062

 Negative

39

21(53.85)

18(46.15)

 

 Positive

83

59(71.08)

24(28.92)

 

PR

122

80

42

0.0591

 Negative

47

26(55.32)

21(44.68)

 

 Positive

75

54(72.00)

21(28.00)

 

HER-2

122

80

42

0.994

 Negative

32

21(65.63)

11(34.38)

 

 Positive

90

59(65.56)

31(34.44)

 

E-cada

87

56

31

0.100

 Negative

6

2(33.33)

4(66.67)

 

 Positive

81

54(66.67)

27(33.33)

 

Ki-67

122

80

42

0.012

 Low

27

20(74.07)

7(25.93)

 

 Moderate

36

29(80.56)

7(19.44)

 

 High

59

31(52.54)

28(47.46)

 

P53

122

80

42

0.126

 Negative

40

30(75.00)

10(25.00)

 

 Positive

82

50(60.98)

32(39.02)

 

Amount of fibroglandular tissue

122

80

42

0.431

 Almost entirely fat/Scattered fibroglandular tissue

49

33(67.35)

16(32.65)

 

 Heterogeneous fibroglandular tissue

54

37(68.52)

17(31.48)

 

 Extreme fibroglandular tissue

19

10(52.63)

9(47.37)

 

Size

122

80

42

0.094

 ≤2cm

79

56(70.89)

23(29.11)

 

 >2cm

43

24(55.81)

19(44.19)

 

Single/multiple

122

80

42

0.746

 Single

95

63(66.32)

32(33.68)

 

 Multiple

27

17(62.96)

10(37.04)

 

Lesions

122

80

42

0.8855

 Mass

65

43(66.15)

22(33.85)

 

 Mass/calcification

57

37(64.91)

20(35.09)

 

Location

122

80

42

0.879

 Outer upper

73

49(67.12)

24(32.88)

 

 Outer lower

5

4(80.00)

1(20.00)

 

 Lower inner

15

10(66.67)

5(33.33)

 

 Upper inner

15

9(60.00)

6(40.00)

 

 Central area

14

8(57.14)

6(42.86)

 

Mass shape

122

80

42

0.160

 Lobulated

16

8(50.00)

8(50.00)

 

 Irregular

106

72(67.92)

34(32.08)

 

Mass Margin

122

80

42

0.088

 Smooth

6

2(33.33)

4(66.67)

 

 Rough

116

78(67.24)

38(32.76)

 

Boundary

122

80

42

0.714

 Clear

69

47(68.12)

22(31.88)

 

 Obscure

27

16(59.26)

11(40.74)

 

 Shield

26

17(65.38)

9(34.62)

 

Calcificationa

56

36

20

0.279

 Vague and amorphous

25

18(72.00)

7(28.00)

 

 Fine polymorphous

31

18(58.06)

13(41.94)

 

Interstitial edema

122

80

42

0.013

 No

110

76(69.09)

34(30.91)

 

 Yes

12

4(33.33)

8(66.67)

 

Subcutaneous fat

122

80

42

0.697

 Clear

101

67(66.34)

34(33.66)

 

 Muddy

21

13(61.90)

8(38.10)

 

Thicken Skin

122

80

42

< 0.001

 No

86

65(75.58)

21(24.42)

 

 Yes

36

15(41.67)

21(58.33)

 

Nipple retraction

122

80

42

0.073

 No

98

68(69.39)

30(30.61)

 

 Yes

24

12(50.00)

12(50.00)

 

Axillary lymph node enlargement

122

80

42

0.166

 No

77

54(70.13)

23(29.87)

 

 Yes

45

26(57.78)

19(42.22)

 
  1. aMissing value exists
  2. LVI Lymphovascular invasion